Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$4.91 USD
+0.04 (0.82%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.90 -0.01 (-0.20%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Aurinia Pharmaceuticals (AUPH) reported earnings of -$0.19 per share, missing the Zacks Consensus Estimate of -$0.18 per share. This reflects a negative earnings surprise of 5.56%. Look out for AUPH's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 5.56%.
Earnings History
Price & Consensus
Zacks News for AUPH
Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AUPH: What are Zacks experts saying now?
Zacks Private Portfolio Services